Nielsen Hldg NV (NYSE:NLSN), On May 12, 2014 announced that it will attend the Bank of America Merrill Lynch Services One-on-One Conference 2014 in New York City on Wednesday, May 21, 2014 and the Sanford Bernstein Annual Strategic Decisions Conference in New York City on Wednesday, May 28, 2014. Mitch Barns, Nielsen’s CEO, will take…
Bonanza Creek Energy Inc (NYSE:BCEI) had its price targetdecreased by Credit Suisse from $62.00 to $61.00 in a research note issued to investors on Wednesday, American Banking and Market News reports. Bonanza Creek Energy Inc (NYSE:BCEI) stock performance was 5.26% in last session and finished the day at $44.83. Traded volume was 1,814,077 shares in…
Time Warner, owner of HBO and the studio behind The Lego Movie, beat the estimates of Wall Street analysts for operations in the first three months of the year, and raised its full-year guidance after getting more money than expected in re-transmission fees from Comcast Corporation (NASDAQ:CMCSA), the country’s largest cable TV operator. Comcast Corporation…
Idera Pharmaceuticals Inc (NASDAQ:IDRA) issued its quarterly earnings data on Tuesday. The company reported ($0.12) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.08) by $0.04, American Banking News reports. Idera Pharmaceuticals Inc (NASDAQ:IDRA) stock performance was 11.02% in last session and finished the day at $2.82. Traded volume was 4,339,672 shares…
Arena Pharmaceuticals, Inc (NASDAQ:ARNA) shares fell 5.1% during trading on Monday after the company announced weaker than expected quarterly earnings, AnalystRatings Network reports. The company traded as low as $6.82 and last traded at $6.82, with a volume of 4,382,908 shares. The stock had previously closed at $7.19. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock performance was…
Idera Pharmaceuticals Inc (NASDAQ:IDRA) announce plans to initiate clinical development of its lead compound, IMO-8400, for the treatment of patients with polymyositis and patients with dermatomyositis, two orphan autoimmune diseases with high unmet clinical needs. Idera Pharmaceuticals Inc (NASDAQ:IDRA) stock performance was 1.23% in last session and finished the day at $ 2.47. Traded volume…
